Advertisement
Canada markets open in 9 hours

  • S&P/TSX

    24,102.71
    -60.12 (-0.25%)
     

  • S&P 500

    5,695.94
    -55.13 (-0.96%)
     

  • DOW

    41,954.24
    -398.51 (-0.94%)
     

  • CAD/USD

    0.7342
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    75.89
    -1.25 (-1.62%)
     

  • Bitcoin CAD

    85,455.29
    -1,226.52 (-1.41%)
     

  • XRP CAD

    0.73
    -0.01 (-1.54%)
     

  • GOLD FUTURES

    2,662.30
    -3.70 (-0.14%)
     

  • RUSSELL 2000

    2,193.09
    -19.71 (-0.89%)
     

  • 10-Yr Bond

    4.0260
    +0.0450 (+1.13%)
     

  • NASDAQ futures

    19,993.00
    +0.25 (+0.00%)
     

  • VOLATILITY

    22.64
    -19.21 (-45.90%)
     

  • FTSE

    8,303.62
    +22.99 (+0.28%)
     

  • NIKKEI 225

    38,821.15
    -511.59 (-1.30%)
     

  • CAD/EUR

    0.6680
    -0.0008 (-0.12%)
     

NeuPath Health Second Quarter 2024 Earnings: EPS: CA$0.005 (vs CA$0.001 in 2Q 2023)

editorial-team@simplywallst.com (Simply Wall St)
·1 min read

NeuPath Health (CVE:NPTH) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CA$18.9m (up 10% from 2Q 2023).

  • Net income: CA$296.0k (up 284% from 2Q 2023).

  • Profit margin: 1.6% (up from 0.4% in 2Q 2023).

  • EPS: CA$0.005 (up from CA$0.001 in 2Q 2023).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

NeuPath Health shares are up 2.6% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for NeuPath Health you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.